AstraZeneca's Crestor May Harm Kidneys
353921
Twenty-nine patients who took  AstraZeneca Plc's AZN.L AZN.N anti-cholesterol drug Crestor  have developed kidney damage, a U.S. consumer group said on  Friday as it called again for a ban on the medicine.
65596
US regulators say recent newspaper ads for AstraZeneca&#39;s Crestor, a cholesterol-lowering drug, are false or misleading. An unusual letter from the Food and Drug Administration, sent Wednesday, dismissed as
425955
DRUGS group AstraZeneca today suffered a massive setback after tests showed its blockbuster Iressa cancer treatment did not allow patients to live longer.
343615
Kidney disease, even in asymptomatic early stages, increases the risk of heart disease, stroke or death, according to a study of more than a million Kaiser Permanente Northern California members.
113293
AstraZeneca was dealt a blow yesterday when an official from the US&#39;s drugs watchdog questioned whether one of its key products ought to be sold in the world&#39;s largest pharmaceuticals market.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
569835
The F.D.A. said that it would consider whether to remove Iressa, a product from AstraZeneca, from the market after the drug failed to prolong the lives of people in a clinical trial.
257852
WASHINGTON Oct 29, 2004 - Consumer advocate Dr. Sidney Wolfe renewed his effort Friday to get the anti-cholesterol drug Crestor removed from sale.
639909
and triple the danger of a stroke. Urinary tract infections, such as cystitis, have the same effect, a study revealed yesterday.
761698
Treatment with Wyeth's drug temsirolimus, which secured U.S. regulatory approval on Wednesday, extended survival for 3 1/2 months for patients with advanced renal-cell carcinoma, according to a company-sponsored study.
433316
AstraZeneca Plc, the UK&#39;s second-biggest drugmaker, delayed the regulatory filing of its diabetes medicine Galida by a year to 2007, a setback that comes a month after US scientists questioned
161543
Shares in pharmaceutical giants AstraZeneca PLC and GlaxoSmithKline PLC tumbled Friday after a US safety official raised concerns over key drugs sold by the companies.
136406
FDA whistle-blower David Graham says Crestor is the only cholesterol-lowering medication, or statin, that causes acute kidney failure, and that it carries a higher risk of rhabdomyolysis, a potentially life-threatening muscle disorder, than other statins.
14666
A US advisory panel on Friday recommended against approving AstraZeneca&#39;s new stroke prevention medication, Exanta, citing concerns about the drug&#39;s effect on the liver.
87521
Newspaper advertising by a manufacturer that defended the cholesterol-lowering drug Crestor made &quot;false or misleading safety claims,&quot; the government said
611882
WASHINGTON Dec 22, 2004 - The Food and Drug Administration is seeking to block an ad touting the safety of the cholesterol drug Crestor, calling the claims misleading.
106113
Shares in AstraZeneca tumbled today after a key drug it has developed in the fight against strokes was provisionally rejected by US regulators.